Elite Pharmaceuticals, Inc.
ELTP
$0.40
$0.000.73%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.59M | 13.70M | -5.88M | 17.00M | -10.89M |
| Total Depreciation and Amortization | 507.20K | 511.10K | 508.30K | 520.50K | 489.60K |
| Total Amortization of Deferred Charges | 3.50K | 3.50K | 3.50K | 3.50K | 3.50K |
| Total Other Non-Cash Items | -10.16M | -5.25M | 27.26M | -4.22M | 11.91M |
| Change in Net Operating Assets | -14.22M | -3.86M | -7.11M | -9.38M | -2.58M |
| Cash from Operations | -5.28M | 5.10M | 14.78M | 3.92M | -1.06M |
| Capital Expenditure | -206.10K | -103.30K | -218.20K | -754.10K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -206.10K | -103.30K | -218.20K | -754.10K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -123.80K | -266.50K | -4.13M | -156.30K | -193.10K |
| Issuance of Common Stock | 90.20K | 150.00K | -- | 19.30K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.60K | -116.50K | -4.13M | -137.00K | -193.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.52M | 4.88M | 10.43M | 3.03M | -1.26M |